In addition, an improvement of at least -0.3 logMAR (+3 lines) from the nadir in at least one eye was observed ... approved in the U.S. LHON is a rare inherited disease that damages the optic ...
The first ApDC to have FDA orphan drug designation globally, the drug was jointly developed by researchers from HIM and Wenzhou Medical University. Orphan drugs are drugs specifically used to treat ...